Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.78 billion. The enterprise value is $1.55 billion.
| Market Cap | 1.78B |
| Enterprise Value | 1.55B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 85.72 million shares outstanding. The number of shares has decreased by -8.31% in one year.
| Current Share Class | 85.72M |
| Shares Outstanding | 85.72M |
| Shares Change (YoY) | -8.31% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 90.61% |
| Float | 79.36M |
Valuation Ratios
The trailing PE ratio is 36.70 and the forward PE ratio is 12.60. Progyny's PEG ratio is 1.50.
| PE Ratio | 36.70 |
| Forward PE | 12.60 |
| PS Ratio | 1.52 |
| Forward PS | 1.40 |
| PB Ratio | 3.79 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | 9.10 |
| P/OCF Ratio | 8.77 |
| PEG Ratio | 1.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.28, with an EV/FCF ratio of 7.94.
| EV / Earnings | 29.62 |
| EV / Sales | 1.28 |
| EV / EBITDA | 20.28 |
| EV / EBIT | 21.27 |
| EV / FCF | 7.94 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.39 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.11% and return on invested capital (ROIC) is 8.41%.
| Return on Equity (ROE) | 10.11% |
| Return on Assets (ROA) | 5.99% |
| Return on Invested Capital (ROIC) | 8.41% |
| Return on Capital Employed (ROCE) | 14.82% |
| Revenue Per Employee | $1.78M |
| Profits Per Employee | $77,201 |
| Employee Count | 680 |
| Asset Turnover | 1.59 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $34.73 million in taxes.
| Income Tax | 34.73M |
| Effective Tax Rate | 39.81% |
Stock Price Statistics
The stock price has decreased by -19.61% in the last 52 weeks. The beta is 1.32, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -19.61% |
| 50-Day Moving Average | 21.90 |
| 200-Day Moving Average | 19.67 |
| Relative Strength Index (RSI) | 41.74 |
| Average Volume (20 Days) | 957,724 |
Short Selling Information
The latest short interest is 6.91 million, so 8.06% of the outstanding shares have been sold short.
| Short Interest | 6.91M |
| Short Previous Month | 6.76M |
| Short % of Shares Out | 8.06% |
| Short % of Float | 8.71% |
| Short Ratio (days to cover) | 5.90 |
Income Statement
In the last 12 months, Progyny had revenue of $1.21 billion and earned $52.50 million in profits. Earnings per share was $0.57.
| Revenue | 1.21B |
| Gross Profit | 266.75M |
| Operating Income | 73.10M |
| Pretax Income | 84.78M |
| Net Income | 52.50M |
| EBITDA | 76.67M |
| EBIT | 73.10M |
| Earnings Per Share (EPS) | $0.57 |
Balance Sheet
The company has $256.12 million in cash and $28.90 million in debt, giving a net cash position of $227.23 million or $2.65 per share.
| Cash & Cash Equivalents | 256.12M |
| Total Debt | 28.90M |
| Net Cash | 227.23M |
| Net Cash Per Share | $2.65 |
| Equity (Book Value) | 467.16M |
| Book Value Per Share | 5.49 |
| Working Capital | 330.56M |
Cash Flow
In the last 12 months, operating cash flow was $203.18 million and capital expenditures -$7.40 million, giving a free cash flow of $195.78 million.
| Operating Cash Flow | 203.18M |
| Capital Expenditures | -7.40M |
| Free Cash Flow | 195.78M |
| FCF Per Share | $2.28 |
Margins
Gross margin is 21.99%, with operating and profit margins of 6.03% and 4.33%.
| Gross Margin | 21.99% |
| Operating Margin | 6.03% |
| Pretax Margin | 7.19% |
| Profit Margin | 4.33% |
| EBITDA Margin | 6.32% |
| EBIT Margin | 6.03% |
| FCF Margin | 16.14% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.31% |
| Shareholder Yield | 8.31% |
| Earnings Yield | 2.95% |
| FCF Yield | 10.99% |
Analyst Forecast
The average price target for Progyny is $22.43, which is 7.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.43 |
| Price Target Difference | 7.89% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 9.07% |
| EPS Growth Forecast (5Y) | 31.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.57 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.57 |
| Piotroski F-Score | 6 |